| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/08/2006 | CN1742881A Chinese medicine composition for treating essential hypotension and preparation method |
| 03/08/2006 | CN1742854A Preparation of the pod of pagoda tree and preparing method thereof |
| 03/08/2006 | CN1742829A Dripping pill for treating coronary heart disease and preparing method |
| 03/08/2006 | CN1742814A Knotweed rhizome glycoside dropping pill, capsule, granules and tablet preparing method for treating cardiovascular and cerebrovascular diseases |
| 03/08/2006 | CN1742808A Medicine composition with synergetic function |
| 03/08/2006 | CN1742806A Mountain green tea dropping pills and preparing method |
| 03/08/2006 | CN1742794A Xinshu preparation and preparing method |
| 03/08/2006 | CN1742793A Medicine composition and use thereof |
| 03/08/2006 | CN1742792A Danhong freez-fried powder injecta and preparing method |
| 03/08/2006 | CN1742790A Qi-circulation promoting soft capsule and preparing method thereof |
| 03/08/2006 | CN1742789A Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparing method thereof |
| 03/08/2006 | CN1742785A Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparing method |
| 03/08/2006 | CN1742783A Natural medicine preparatino for tonifying Qi strengthening body resistance and preparing method |
| 03/08/2006 | CN1742766A Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparation method |
| 03/08/2006 | CN1742743A Pseudo-ginseng saponin oral disintegration tablet and preparing method |
| 03/08/2006 | CN1742736A Buckthorn extract, its preparing method and use in pharmaceutical process |
| 03/08/2006 | CN1742726A Piperazine ferulate oral cavity disintegrating tablet and preparing method |
| 03/08/2006 | CN1742725A Tirofiban hydrochloride freeze-dried powder injecta and preparing method |
| 03/08/2006 | CN1742722A Method for resisting blood vessel generation |
| 03/08/2006 | CN1742719A Bilobanoate oral-cavity disintegrating tablet and preparation method |
| 03/08/2006 | CN1742713A Method for preparing sodium ferulate sterilized raw-material medicine |
| 03/08/2006 | CN1244688C Microbe and process for preparing pravastatin sodium |
| 03/08/2006 | CN1244686C Lactobacillus casei LC2W strain and its application in treatment of hypertension |
| 03/08/2006 | CN1244589C 腺苷a3受体激动剂 A3 adenosine receptor agonists |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244578C Substituted benzofuran-2-carboxamides derivatives |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244574C Method for preparing water-soluble soybean aglycon and its applications |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/08/2006 | CN1244558C 1,2-hydrindene or indoline derivative |
| 03/08/2006 | CN1244542C Aromatic amine derivatives having NOS inhibitory effect |
| 03/08/2006 | CN1244372C Chinese medicinal preparation for treating cardiac blood vessel disease and its preparation method |
| 03/08/2006 | CN1244363C Liver cirrhosis and arteriosclerosis pharmaceutical composition |
| 03/08/2006 | CN1244355C Series medicament of zanthoxylum bungeanum seed kernel oil and pseudo-ginseng total saponin and preparing process thereof |
| 03/08/2006 | CN1244354C Series medicament of zanthoxylum bungeanum seed kernel oil and red-rooted salvia root alcohol extract and preparing process thereof |
| 03/08/2006 | CN1244352C Toxicant-elimination soup of rhizome of Chinese goldthread and new use of its active part |
| 03/08/2006 | CN1244348C Series alkaloid medicament of hot spice plant seed embryo kernel oil and Chuanxiong rhizome and preparing process thereof |
| 03/08/2006 | CN1244345C Chinese medicine composition for treating thromboangiitis obliterans and its preparing method |
| 03/08/2006 | CN1244340C Chinese medicine for treating coronary heart disease and angina pectoris and its preparing process |
| 03/08/2006 | CN1244337C Natural medicated health food for preventing and treating diabetes and cardiac vascular diseases induced thereby |
| 03/08/2006 | CN1244333C Rhodiola root powdery injection and its preparation |
| 03/08/2006 | CN1244323C Novel fatty acid analogues for the treatment of primary and secondary restenosis |
| 03/08/2006 | CN1244281C Compositions comprising edible oils or fats and phytosterols and/or phytostanols substantially dissolved therein |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7009053 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 03/07/2006 | US7009049 Syntheses of quinazolinones |
| 03/07/2006 | US7009036 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 03/07/2006 | US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections |
| 03/07/2006 | US7008959 Preparing a novel crystal form by sonication and temperature oscillation of a suspension; filtered and dried faster; treating cardiovascular disorders |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008940 1,6,7,8-tetrahydro-2,2,4,5-tetramethyl-1-(4-methylphenyl)-2H-furo[3,2-e]indole for example; inhibiting lipoperoxide production (antioxidant); treating restenosis after percutaneous transluminal coronary angioplasty; Alzheimer's disease |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008773 Method for identifying active anti apoptosis compounds |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/02/2006 | WO2006023865A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 03/02/2006 | WO2006023639A1 Methods and compositions for oral delivery of fts |
| 03/02/2006 | WO2006022374A1 2-phenylpyridine derivative |
| 03/02/2006 | WO2006022356A1 Process for producing microorganism fat containing diacylglycerol in any amount and the fat |
| 03/02/2006 | WO2006022338A1 Dry powder of pseudo leaf tissue of plant belonging to the genus asparagus |
| 03/02/2006 | WO2006022187A1 Coenzyme q10-containing composition |
| 03/02/2006 | WO2006022091A1 Method of culturing human bone marrow-origin mesenchymal stem cells using human serum medium |
| 03/02/2006 | WO2006021418A1 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 03/02/2006 | WO2005117858A3 Compositions comprising nebivolol |
| 03/02/2006 | WO2005019429A3 Compositions and methods for enhancing phagocytosis or phagocyte activity |
| 03/02/2006 | US20060046995 anti-bacterial agents; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen |
| 03/02/2006 | US20060046992 Heterobicyclic compounds |
| 03/02/2006 | US20060045853 Using tissue plasminogen activator finger domain specific immunolglobulins as tool in diagnosis of diabbetes and/or alzheimer's disease |
| 03/02/2006 | DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases |
| 03/02/2006 | DE102004041270A1 Ein Kapillar- Wirksystem enthaltende Zusammensetzungen mit anwendungsbezogener Differenzierbarkeit und deren Verwendung A capillary containing active system compositions with application-specific differentiation and their use |
| 03/02/2006 | DE102004039507A1 Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted 8-Aminoalkoxi-xanthines, processes for their preparation and their use as medicaments |
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2577857A1 Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 03/02/2006 | CA2577748A1 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 03/02/2006 | CA2577676A1 Process for production of microbial fat/oil containing discretional amount of diacylglycerol and said fat/oil |
| 03/02/2006 | CA2577084A1 Bicyclononene derivatives as renin inhibitors |
| 03/02/2006 | CA2575078A1 Lercanidipine salts |
| 03/02/2006 | CA2574454A1 Aminopiperidine derivatives, preparation thereof and use thereof as melanocortin receptor agonists |
| 03/01/2006 | EP1630164A1 Pyrazolopyrimidinones as phosphodiesterase inhibitors |
| 03/01/2006 | EP1630162A1 2-aminoquinoline derivative |
| 03/01/2006 | EP1629853A1 Method for preparing powder exhibiting low susceptibility to electrification |
| 03/01/2006 | EP1629849A2 Pharmaceutical compositions comprising exendins and agonists thereof |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628977A2 ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES |
| 03/01/2006 | EP1628968A1 4-imidazolin-2-one compounds |
| 03/01/2006 | EP1628682A2 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 03/01/2006 | EP1503753A4 A method for inhibiting platelet aggregation |
| 03/01/2006 | EP1494691A4 Treatment of diseases involving defective gap junctional communication |
| 03/01/2006 | EP1472255B1 Aza-arylpiperazines |
| 03/01/2006 | EP1414426B1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 03/01/2006 | EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 03/01/2006 | EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 03/01/2006 | EP1339710B1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 03/01/2006 | EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1307192B1 Candesartan for treating migraine |
| 03/01/2006 | EP1233962B1 Novel heterocyclic compounds and their use as medicines |
| 03/01/2006 | EP1135394B1 Spirocyclic thienopyrans as potassium channel activators |